Chinook Therapeutics Inc. buy melinda
Start price
30.06.17
/
50%
€57.50
Target price
11.07.17
€67.50
Performance (%)
11.30%
End price
11.07.17
€64.00
Summary
This prediction ended on 11.07.17 with a price of €64.00. The prediction had a final performance of 11.30%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Chinook Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% | 23.659% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% | 41.786% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% | 6.454% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% | 42.511% |
Comments by melinda for this prediction
In the thread Aduro Biotech Inc. diskutieren
Leitet Phase 2 der klinischen Prüfung CRS-207 in Kombination mit KEYTRUDA für die Behandlung der gastroösophagealen Adenocarcinoma
(Vom Mitglied beendet)
Stopped prediction by melinda for Chinook Therapeutics Inc.
Chinook Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.50
14.03.20
14.03.20
€17.50
04.11.21
04.11.21
33.33%
05.11.21
05.11.21
Chinook Therapeutics Inc.
Start price
Target price
Perf. (%)
€13.00
09.02.20
09.02.20
-
14.03.20
14.03.20
-19.23%
14.03.20
14.03.20
Chinook Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.10
07.02.20
07.02.20
-
09.02.20
09.02.20
7.44%
09.02.20
09.02.20
Chinook Therapeutics Inc.
Start price
Target price
Perf. (%)
€18.85
05.05.19
05.05.19
€32.47
12.06.19
12.06.19
-55.86%
12.06.19
12.06.19
Chinook Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.66
28.10.17
28.10.17
€47.36
19.03.18
19.03.18
9.58%
19.03.18
19.03.18
Chinook Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.75
28.10.17
28.10.17
€52.50
19.03.18
19.03.18
9.58%
19.03.18
19.03.18
Chinook Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.87
30.06.17
30.06.17
€60.89
11.07.17
11.07.17
11.30%
11.07.17
11.07.17
Chinook Therapeutics Inc.
Start price
Target price
Perf. (%)
€61.38
17.04.16
17.04.16
€67.65
25.04.16
25.04.16
10.95%
25.04.16
25.04.16